Albuminuria is Associated With Subendocardial Viability Ratio in Chronic Kidney Disease Patients

被引:30
|
作者
Ekart, Robert [1 ]
Bevc, Sebastjan [2 ]
Hojs, Nina [2 ]
Knehtl, Masa [2 ]
Dvorsak, Benjamin [2 ]
Hojs, Radovan [2 ]
机构
[1] Univ Med Ctr Maribor, Clin Internal Med, Dept Dialysis, SI-2000 Maribor, Slovenia
[2] Univ Med Ctr Maribor, Clin Internal Med, Dept Nephrol, SI-2000 Maribor, Slovenia
来源
KIDNEY & BLOOD PRESSURE RESEARCH | 2015年 / 40卷 / 06期
关键词
Albuminuria; Chronic kidney disease; Pulse-wave analysis; AUGMENTATION INDEX; BLOOD-PRESSURE; REPRODUCIBILITY; MORTALITY;
D O I
10.1159/000368532
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background/Aims: Albuminuria is a well-established marker of subclinical organ damage. Pulse-wave analysis (PWA) employs the technique of applanation tonometry to obtain a peripheral pulse pressure waveform, from which central hemodynamic data are derived by application of the transfer function. Using PWA we can measure the subendocardial viability ratio (SEVR) and ejection duration (ED). SEVR or the Buckberg index is a non-invasive estimate of myocardial workload, oxygen supply and perfusion and a measure of the ability of the arterial system to meet the heart's energy requirements. ED is the duration of ventricular ejection. The objective of this study was to evaluate the relationship between albuminuria and PWA parameters in chronic kidney disease (CKD) patients. Methods: We studied 86 CKD patients aged 59.8 +/- 13.5 years, 56 (65.1%) were male. PWA analysis and 24-hour ambulatory blood pressure (24hABP) monitoring were performed. The following parameters were calculated: (1) aortic augmentation index with and without correction for a heart rate of 75 (Aix and AIx@HR75), (2) SEVR, calculated as the ratio of the diastolic pressure time index and the systolic pressure time index, (3) ED, (4) estimated central aortic systolic and diastolic pressure and (5) central aortic pulse pressure calculated as the difference between estimated aortic systolic and diastolic BP. Blood samples and urine albumin-to-creatinine ratio (UACR) were analyzed; UACR values were natural log transformed (lnUACR). Results: Using CKD-EPI creatinine-cystatin C formula the eGFR in patients was 7-130 ml/min/1.73m(2) (mean 32.6; SD +/- 24.6). We found statistically significant correlation between lnUACR and cystatin C (r= 0.308; P= 0.004), eGFR (r=-0.219; P= 0.04), hemoglobin (r=-0.255; P= 0.02), phosphorus (r= 0.222; P= 0.04), iPTH (r= 0.268; P= 0.01), SEVR (r=-0.254; P= 0.02) and ED (r= 0.315; P= 0.003). No statistically significant correlations between lnUACR and cardiac biomarkers TnI, NT-proBNP, central aortic BP and 24h ABP values were found. Using multiple regression analysis statistically significant association was found between SEVR as dependent variable and lnUACR (beta=-0.223, P= 0.039), sex (beta=-0.216, P=0.035), and diabetes (beta=0.332, P=0.001). Multiple regression analysis with ED as dependent variable has shown statistically significant association with lnUACR (beta=0.242, P=0.031) and diabetes (beta=-0.275, P=0.01). Patients were stratified into tertiles according to the lnUACR. Statistically significant differences in serum creatinine (P=0.001), cystatin C (P=0.012), hemoglobin (P=0.03), calcium (P=0.036), iPTH (P=0.008), SEVR (P=0.007) and ED (P=0.004) were found between tertiles. In post hoc analysis we found statistically significant differences between first and third tertile in SEVR (P=0.002; 95% CI: 10.5-45) and in ED (P=0.001; 95% CI:6.89-(-1.87)). Conclusions: Nondialysis CKD patients with higher levels of albuminuria have lower SEVR and higher ED and our results have shown the importance of central hemodynamic parameters like are SEVR and ED as a better or earlier noninvasive hemodynamic indexes in these patients. (C) 2015 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:565 / 574
页数:10
相关论文
共 50 条
  • [31] ALBUMINURIA DURING AND AFTER PARICALCITOL TREATMENT IN CHRONIC KIDNEY DISEASE PATIENTS
    Ekart, Robert
    Hojs, Nina
    Bevc, Sebastjan
    Hojs, Radovan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 376 - 376
  • [32] URINARY INDICES FOR ESTIMATION OF ALBUMINURIA AND PROTEINURIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Kim, Gheun-Ho
    Oh, Il Hwan
    Park, Joon-Sung
    Lee, Chang Hwa
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [33] Dapagliflozin Improves the Clinical Outcomes of Patients with Chronic Kidney Disease and Albuminuria
    Stephanie A. Patrick
    Tracey D. Dabal
    Christopher D. Jackson
    Journal of General Internal Medicine, 2021, 36 : 2915 - 2917
  • [34] Dapagliflozin Improves the Clinical Outcomes of Patients with Chronic Kidney Disease and Albuminuria
    Patrick, Stephanie A.
    Dabal, Tracey D.
    Jackson, Christopher D.
    Halalau, Alexandra
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (09) : 2915 - 2917
  • [35] Association between albuminuria and thyroid function in patients with chronic kidney disease
    Walter Reinhardt
    Nils Mülling
    Stefan Behrendt
    Sven Benson
    Sebastian Dolff
    Dagmar Führer
    Susanne Tan
    Endocrine, 2021, 73 : 367 - 373
  • [36] Albuminuria, But Not eGFR, Predicts Stroke Risk In Patients With Chronic Kidney Disease
    Sandsmark, Danielle K.
    Messe, Steven R.
    Zhang, Xiaoming
    Roy, Jason
    Kasner, Scott E.
    STROKE, 2013, 44 (02)
  • [37] Association of serum adiponectin level with albuminuria in chronic kidney disease patients
    Ha Yeon Kim
    Eun Hui Bae
    Seong Kwon Ma
    Dong Wan Chae
    Kyu Hun Choi
    Yong-Soo Kim
    Young-Hwan Hwang
    Curie Ahn
    Soo Wan Kim
    Clinical and Experimental Nephrology, 2016, 20 : 443 - 449
  • [39] Chronic Kidney Disease and Albuminuria in Arterial Hypertension
    Leoncini, Giovanna
    Viazzi, Francesca
    Pontremoli, Roberto
    CURRENT HYPERTENSION REPORTS, 2010, 12 (05) : 335 - 341
  • [40] Parity is associated with albuminuria and chronic kidney disease: a population-based study
    Sun, Kan
    Lin, Diaozhu
    Feng, Qiling
    Li, Feng
    Qi, Yiqin
    Huang, Chulin
    Feng, Wanting
    Yang, Chuan
    Yan, Li
    Ren, Meng
    AGING-US, 2019, 11 (23): : 11030 - 11039